Anita Jansen

Title: Anita Jansen: Innovator in Gastrointestinal Disease Detection

Introduction

Anita Jansen is a notable inventor based in Turku, Finland. She has made significant contributions to the field of medical diagnostics, particularly in the detection of inflammatory gastrointestinal tract diseases. Her innovative approach has the potential to improve patient outcomes through early detection and intervention.

Latest Patents

Anita Jansen holds a patent for a method that determines the likelihood of an inflammatory gastrointestinal tract disease. The method involves diluting a biological sample from a human subject and contacting it with 8-anilinonaphthalene-1-sulfonic acid as a modulating agent. This is followed by the addition of a reagent that includes a peroxidase enzyme and a label selected from europium chloride and terbium chloride. The sample is then incubated and excited, allowing for the measurement of the time-resolved luminescence signal of the label. If the luminescence signal is at least 112% higher than that of a control sample from a human subject without an inflammatory intestinal disease, an increased likelihood of such a disease is determined.

Career Highlights

Anita Jansen is currently associated with Aqsens Health Oy, where she continues to develop innovative solutions in health technology. Her work focuses on enhancing diagnostic methods that can lead to better healthcare solutions.

Collaborations

Anita collaborates with talented professionals in her field, including Janne Kulpakko and Riikka Erkkilä. Their combined expertise contributes to the advancement of medical diagnostics and innovation.

Conclusion

Anita Jansen's contributions to the field of gastrointestinal disease detection exemplify the impact of innovation in healthcare. Her patented method represents a significant advancement in diagnostic technology, showcasing her dedication to improving patient care.